DB
GILD icon

Danske Bank’s Gilead Sciences GILD Stock Holding History

Danske Bank’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$106M Sell
840,400
-16,993
-2% -$2.24M 0.21% 81
2026
Q1 		$119M Sell
857,393
-295,715
-26% -$41.4M 0.29% 61
2025
Q4 		$142M Sell
1,153,108
-45,529
-4% -$5.53M 0.33% 51
2025
Q3 		$133M Sell
1,198,637
-44,768
-4% -$5.09M 0.33% 50
2025
Q2 		$138M Buy
1,243,405
+240,607
+24% +$25.6M 0.34% 53
2025
Q1 		$112M Buy
1,002,798
+197,182
+24% +$20.3M 0.34% 50
2024
Q4 		$74.4M Buy
805,616
+286,297
+55% +$25.8M 0.22% 75
2024
Q3 		$43.5M Buy
519,319
+10,420
+2% +$795K 0.15% 131
2024
Q2 		$34.9M Sell
508,899
-58,274
-10% -$3.89M 0.13% 146
2024
Q1 		$41.5M Buy
+567,173
New +$43.6M 0.13% 146

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Danske Bank's GILD Position: Q2 2026 in Review

Danske Bank reduced its Gilead Sciences (GILD) stake by 2% in Q2 2026, selling an estimated $2.24M and leaving 840,400 shares worth $106M. The position accounts for 0.21% of the portfolio, ranked #81.

Danske Bank first reported a position in GILD in Q1 2024 and has held it in 10 quarters since. The position peaked at $142M in Q4 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Danske Bank held 840,400 shares of Gilead Sciences worth $106M as of Q2 2026.
  • Danske Bank sold 16,993 Gilead Sciences shares in Q2 2026, an estimated $2.24M.
  • Gilead Sciences made up 0.21% of Danske Bank's portfolio in Q2 2026, its #81 holding.
  • Danske Bank first reported a position in Gilead Sciences in Q1 2024 and has held it in 10 quarters since.
  • Danske Bank's Gilead Sciences position peaked at $142M in Q4 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.